Latest Breaking News On - Rajarshi banerjee - Page 4 : comparemela.com

AI comes of age during Covid-19: Register now and join us for MedCity INVEST in Chicago

The conference takes place March 28-30 at the Ritz Carlton hotel in Chicago. Register now and be part of the conversation, take part in networking opportunities and check out startup pitches across pharma tech, medtech, diagnostics, and digital health.

Paige, Perspectum forge AI-centered clinical trial alliance

New Partnership Between Marubeni/Clairvo and Perspectum to Bring LiverMultiScan to Japan

Perspectum announced that it has signed a strategic business partnership with Marubeni Corporation ("Marubeni") to support entry of Perspectum's AI diagnostic technology, called LiverMultiScan, into

Coronavirus impact: Seafood exports to China takes a major hit

Coronavirus impact: Seafood exports to China takes a major hit SECTIONS Share Synopsis Non-payments, as also delayed payments, by many importers in China and allegedly unreasonable post-shipment, transhipment and vessel waiting charges by shipping lines have become a regular feature, with no intervention from India’s trade authorities, said exporters. Agencies Exporters also said that freight rates have been progressively increased for reefer containers to the US to about $6,500 from $3,500 in March 2020. Marine exports from India, mainly from the west coast of the country, have taken a hit as Chinese buyers fear the presence of Covid-19 in the packing material. China accounts for nearly 25% of India s marine exports. Seafood exporters said they are facing the brunt of non-payments and delayed payments by many Chinese importers.

Perspectum Appoints Annalisa Jenkins, MBBS, FRCP to Board of Directors

Perspectum Appoints Annalisa Jenkins, MBBS, FRCP to Board of Directors Perspectum, a commercial-stage, precision-health company developing proprietary digital technologies that enable clinicians to more accurately diagnose and monitor patients with chronic metabolic diseases, multi-organ pathologies and cancer, announced the appointment of Annalisa Jenkins, MBBS, FRCP to its Board of Directors. Dr. Jenkins brings extensive expertise in advancing biopharma programs from discovery to regulatory approval, which she gained during a distinguished industry career, including roles as the former head of Global R&D for Merck Serono and Head of Global Medical Affairs for Bristol Myers Squibb. Over her 20-year career, she has served as a chairwoman or director on the board of 14 public and private companies, including Oncimmune, a company focused on the diagnosis and treatment of cancer. Dr. Jenkins is the current chair of the court at the London School of Hygiene and Tropical Medicine, a co